Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening

20 Dec 2019

Abstract excerpt

Objectives Many countries use faecal immunochemical testing (FIT) to screen for colorectal cancer. There is increasing evidence that faecal microbiota play a crucial role in colorectal cancer carcinogenesis. We assessed the possibility of measuring faecal microbial features in FIT as potential future biomarkers in colorectal cancer screening. Methods Bacterial stability over time and the possibility of bacterial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Fecal contamination and water quality
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32213018
DOI: 10.1177/2050640619890732

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screeningPMID 32213018Read ↗

Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screeningSemantic proximity Read ↗

Reproducible profiling of the gut microbiota using surplus clinical Faecal Immunochemical Test (FIT) samplesSemantic proximity Read ↗

Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasiaSemantic proximity Read ↗

The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal CancerSemantic proximity Read ↗

A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic EffectSemantic proximity Read ↗

DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based modelSemantic proximity Read ↗

DNA from fecal immunochemical test can replace stool for microbiota-based colorectal cancer screeningSemantic proximity Read ↗

Intratumoural pks Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeSemantic proximity Read ↗

Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria AnalysisSemantic proximity Read ↗

Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial loadSemantic proximity Read ↗

Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypesSemantic proximity Read ↗

Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.